# Effect Of Acetazolamide On Altitude Related Illness In Patients With Respiratory Disease

> **NCT03156231** · PHASE4 · COMPLETED · sponsor: **University of Zurich** · enrollment: 185 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** ACETAZOLAMIDE oral capsule
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03156231
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-24
- **Primary completion:** 2018-08-02
- **Final completion:** 2018-08-02
- **Target enrollment:** 185 (ACTUAL)
- **Last updated:** 2019-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03156231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03156231, "Effect Of Acetazolamide On Altitude Related Illness In Patients With Respiratory Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03156231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*